Detail page

Knowledge Web

Person

Holger Sültmann (1962-)

Biologe

Name	Holger Sültmann
Time	1962- (Date of birth and death)
Place	Deutschland
Academic degree	Prof. Dr. Dr.
Profession	Biologe (characteristic profession)
Further information	1991 Diploma in Biochemistry, University of Tübingen; 1994 Dr. rer. nat. (PhD), University of Tübingen; 2000-2010 Group head, Div. of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg; 2001 Habilitation in Genetics, University of Tübingen; 2012 Full professor for Applied Genome Research, Medical Faculty, Heidelberg University; Translational Lung Research Center Heidelberg, Universitätsklinikum Heidelberg; Nationales Centrum für Tumorerkrankungen (NCT), Klinikum der Universität Heidelberg
Record type	Person
GND-Identifier	172777291
Record ID	172777291
Involved in show all Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients The DKTK EXLIQUID consortium – exploiting liquid biopsies to advance cancer precision medicine for molecular tumor board patients Genome-wide epigenomic analyses of cell-free DNA from anaplastic lymphoma kinase-rearranged non-small cell lung cancer patients Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis The influence of cancer-associated fibroblasts on drug resistance of anaplastic lymphoma kinase-mutated lung adenocarcinoma cells Characterization of the lung extracellular matrix and its remodeling mechanisms : impact on idiopathic pulmonary fibrosis and lung adenocarcinoma Genome-wide DNA methylation profiling in early stage I lung adenocarcinoma reveals predictive aberrant methylation in the promoter region of the long noncoding RNA PLUT: an exploratory study Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA The ERG-driven long non-coding RNA LINC00920 promotes cell proliferation and migration in prostate cancer cells by modulating FOXO activity through a direct interaction with 14-3-3ε The landscape of viral associations in human cancers The BRCA2 mutation status shapes the immune phenotype of prostate cancer Digital PCR After MALDI–Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1–ALK-rearranged lung cancer Correlation between genomic index lesions and mpMRI and 68Ga-PSMA-PET/CT imaging features in primary prostate cancer Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance Genomic features of renal cell carcinoma with venous tumor thrombus Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity Dependence of Intracellular and Exosomal microRNAs on Viral E6/E7 Oncogene Expression in HPV-positive Tumor Cells Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation Linkage relationships and haplotype polymorphism among cichlid Mhc class II B loci TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling Targeted high throughput sequencing in clinical cancer Settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Holger Sültmann (1962-)

Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients

The DKTK EXLIQUID consortium – exploiting liquid biopsies to advance cancer precision medicine for molecular tumor board patients

Genome-wide epigenomic analyses of cell-free DNA from anaplastic lymphoma kinase-rearranged non-small cell lung cancer patients

Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis

The influence of cancer-associated fibroblasts on drug resistance of anaplastic lymphoma kinase-mutated lung adenocarcinoma cells

Characterization of the lung extracellular matrix and its remodeling mechanisms : impact on idiopathic pulmonary fibrosis and lung adenocarcinoma

Genome-wide DNA methylation profiling in early stage I lung adenocarcinoma reveals predictive aberrant methylation in the promoter region of the long noncoding RNA PLUT: an exploratory study

Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA

The ERG-driven long non-coding RNA LINC00920 promotes cell proliferation and migration in prostate cancer cells by modulating FOXO activity through a direct interaction with 14-3-3ε

The landscape of viral associations in human cancers

The BRCA2 mutation status shapes the immune phenotype of prostate cancer

Digital PCR After MALDI–Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma

Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1–ALK-rearranged lung cancer

Correlation between genomic index lesions and mpMRI and 68Ga-PSMA-PET/CT imaging features in primary prostate cancer

Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance

Genomic features of renal cell carcinoma with venous tumor thrombus

Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories

Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy

Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity

Dependence of Intracellular and Exosomal microRNAs on Viral E6/E7 Oncogene Expression in HPV-positive Tumor Cells

Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation

Linkage relationships and haplotype polymorphism among cichlid Mhc class II B loci

TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling

Targeted high throughput sequencing in clinical cancer Settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity